We have located links that may give you full text access.
Case Reports
Journal Article
A novel use of cardiac resynchronization therapy-defibrillator device in hypertrophic cardiomyopathy.
Annals of Noninvasive Electrocardiology 2019 January
Dual-chamber implantable cardioverter-defibrillator is generally used in patients with atrioventricular block and hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. In the current case, a cardiac resynchronization therapy-defibrillator device was implanted in a patient with non-obstructive hypertrophic cardiomyopathy with preserved ejection fraction and atrioventricular block to achieve both more physiological pacing and life-threatening ventricular arrhythmia management.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app